At 76 years old, Pedro Lopez loves to play golf and keep a full schedule as a husband of 53 years, a father and a grandfather ...

"This is a very promising tool. So I feel like it can be employed very well. That's why I am not in the bracket of people who are overly worried about it," he says.

One HHS research project cited by the Times ultimately seeks to use autonomous AI to help manage heart failure patients, ...

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced ...

Moderna built an artificial intelligence that reads a patient’s tumor and decides what that patient’s medicine should be.

Moderna and Merck's Phase 3 melanoma vaccine trial showed positive results, but full data and FDA approval are still pending ...

WASHINGTON – Today, Congressman Michael McCaul (R-Texas) — founder and co-chair of the Congressional Childhood Cancer Caucus ...

Eric Lefkofsky, Tempus AI founder and CEO, joins 'The Exchange' to discuss AI's role in healthcare, advancing cancer research ...

Eric Lefkofsky, Tempus AI founder and CEO, joins 'The Exchange' to discuss AI's role in healthcare, advancing cancer research ...

Trump, who undoubtedly sets the tone for Hill Republicans, said that the only regulation that AI needs is “a STRONG AND SMART ...

CMI will continue utilizing its considerable AI assets, but Agility is evidence that the agency’s plan is to be more ...

AI companies risk losing control of AI systems and shouldn't wait for governments to regulate the technology, OpenAI Chief Executive Sam Altman has said. Dell's DFO-Led Consortium Taking Baldwin Group ...